This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Ovarian Cancer
  • /
  • Single agent trabectedin in heavily pretreated pat...

Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer

Read time: 1 mins
Published:1st Oct 2017
Author: Adam JP, Boumedien F, Letarte N, Provencher D.
Availability: Pay for access, or by subscription
Ref.:Gynecol Oncol. 2017;147(1):47-53.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest